Mostrando 3 resultados de: 3
Filtros aplicados
Publisher
European Urology Open Science(1)
Minerva Urology and Nephrology(1)
World Journal of Urology(1)
Origen
scopus(3)
Androgen receptor axis-targeted agents for non-metastatic castration-resistant prostate cancer impact on overall survival and safety profile
ReviewAbstract: inTrodUCTion: The management of non-metastatic castration-resistant prostate cancer (nmCrpC) has undPalabras claves:Apalutamide, Castration, Darolutamide, Enzalutamide, Network meta-analysis, prostatic neoplasmsAutores:Briganti A., Diego M. Carrión, Egawa S., Esperto F., Fiori C., Grossmann N.C., Katayama S., Kimura T., Laukhtina E., Mori K., Mostafaei H., Motlagh R.S., Papalia R., Ploussard G., Pradere B., Quhal F., Rajwa P., Schuettfort V.M., Shariat S.F.Fuentes:scopusCurrent application of the enhanced recovery after surgery protocol for patients undergoing radical cystectomy: lessons learned from European excellence centers
ArticleAbstract: Purpose: There is no consensus on which items of Enhanced Recovery After Surgery (ERAS) should and sPalabras claves:Autores:Abufaraj M., Albisinni S., Aziz A., Cimadamore A., Di Trapani E., Diego M. Carrión, D’Andrea D., Flippot R., Gonsette K., Khalifa J., Krajewski W., Laukhtina E., Mari A., Mori K., Moschini M., Pradere B., Soria F., Tan W.S., Teoh J.Y.C.Fuentes:scopusThe Impact of Primary Versus Secondary Muscle-invasive Bladder Cancer at Diagnosis on the Response to Neoadjuvant Chemotherapy
ArticleAbstract: Background: There might be differential sensitivity to neoadjuvant chemotherapy (NAC) in patients wiPalabras claves:bladder cancer, Neoadjuvant chemotherapy, Primary, Response, Secondary, SurvivalAutores:Alvarez-Maestro M., Brönimann S., De Berardinis E., del Giudice F., Di Maida F., Di Trapani E., Diego M. Carrión, D’Andrea D., Filippot R., Grisay G., Hendricksen K., Krajewski W., Laukhtina E., Maggi M., Mari A., Mertens L.S., Moschini M., Paulnsteiner D., Pichler R., Pradere B., Shariat S.F., Soria F., Vallet S., van Rhijn B.W.G.Fuentes:scopus